Affymetrix, Inc.
|
Balance Sheet Cash Flow Statement 3420 Central Expwy. Santa Clara, CA 95051 CA Tel. 408-731-5000 Toll Free 888-362-2447 Fax 408-731-5441 |
Type: Public
On the web:
http://www.affymetrix.com
Employees:
1,141
Employee growth: 1.2%
Affymetrix detects the secrets of human genetics. Its GeneChip system and other products are used to identify, analyze, and manage genetic data in the development of new treatments for infectious diseases, cancer, and other ailments. Affymetrix sells its products directly to drugmakers, academic research labs, and government agencies in its key North American and European markets. It has partnerships with such companies as Roche and Johnson & Johnson subsidiary Veridex to develop disease diagnostics using its GeneChip technology. The company owns about 20% of Perlegen Sciences, which uses Affymetrix's technology to map genetic variations and tie them to human health for drug development.
Key numbers for fiscal year ending December, 2007:
Sales: $371.3M
One year growth: 4.5%
Net income: $12.6M
Officers:
Chairman and CEO: Stephen P. A. (Steve) Fodor
President: Kevin M. King
EVP, CFO, Treasurer, and Principal Financial Officer: Scientific & Technical Instruments
Competitors:
Applied Biosystems
BD Biosciences
Beckman Coulter
